Hot Pursuit     08-Sep-23
J B Chemicals CFO Lakshay Kataria resigns
Kataria will be relieved from his duties effective end of business hours on 30 November 2023.
Lakshay Kataria, the chief financial officer and key managerial personnel of J B Chemicals & Pharmaceuticals, has submitted his resignation due to personal reasons. His resignation will be effective from the end of business hours on 30 November 2023.

"The company is in the process of appointing a new chief financial officer and the same will be communicated to the stock exchanges in due course," J B Chemicals & Pharmaceuticals said in a statement.

J B Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). On a consolidated basis, the company's net profit rose 35.50% to Rs 142.32 crore on 14.19% increase in net sales to Rs 896.20 crore in Q1 June 2023 over Q1 June 2022.

Previous News
  Benchmarks off day's high; metal shares advance
 ( Market Commentary - Mid-Session 12-Jun-23   14:36 )
  J B Chemicals & Pharmaceuticals Ltd Slides 1.69%
 ( Hot Pursuit - 22-Sep-23   09:45 )
  Volumes spurt at Kotak Mahindra Bank Ltd counter
 ( Hot Pursuit - 29-Feb-24   11:00 )
  J B Chemicals & Pharmaceuticals to hold AGM
 ( Corporate News - 01-Jul-23   18:36 )
  J B Chemicals & Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 29-Jul-22   18:52 )
  J B Chemicals & Pharmaceuticals consolidated net profit declines 11.64% in the June 2022 quarter
 ( Results - Announcements 05-Aug-22   08:15 )
  J.B.Chemicals Gujarat facilty clears USFDA inspection
 ( Hot Pursuit - 12-Jun-23   13:26 )
  J B Chemicals & Pharmaceuticals Ltd eases for fifth straight session
 ( Hot Pursuit - 26-Jun-24   13:35 )
  J B Chemicals & Pharmaceuticals announces board meeting date
 ( Corporate News - 11-May-24   12:06 )
  J B Chemicals & Pharmaceuticals consolidated net profit rises 3.29% in the March 2023 quarter
 ( Results - Announcements 24-May-23   18:02 )
  J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
 ( Corporate News - 30-Nov-22   16:24 )
Other Stories
  Shalby drops after PAT slides 20% YoY to Rs 16 cr in Q1 FY25
  08-Jul-24   16:01
  Tata Steel Production rises 5% YoY in Q1 FY24
  08-Jul-24   15:54
  PC Jeweller soars after PNB approves settlement
  08-Jul-24   15:26
  Godrej Inds gains after chemicals arm inks BTA to acquire Ethoxylation Unit II
  08-Jul-24   15:22
  GE Power sizzles after NTPC order win
  08-Jul-24   15:02
  Patel Engineering Ltd leads losers in 'A' group
  08-Jul-24   15:01
  Sundaram Multi Pap Ltd leads losers in 'B' group
  08-Jul-24   14:46
  Marine Electricals jumps after order win
  08-Jul-24   14:33
  Volumes soar at Metro Brands Ltd counter
  08-Jul-24   14:30
  Bank of India Q1 domestic deposits grow 10% YoY
  08-Jul-24   14:25
Back Top